Russell Harris
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Russell Harris has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Kathleen N. Lohr
3 shared publicationsLinda Kinsinger
Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA
3 shared publicationsBritt Peterson
2 shared publicationsLinda S. Kinsinger
University of North Carolina at Chapel Hill Chapel Hill 27599-7590 NC
2 shared publicationsMalaz Boustani
2 shared publications- Alison Tytell Brenner
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
1 shared publication
Latest Publications
- 1 November 2022
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 175 (11) , 1610-1611
Cancer Screening Guidelines Are Not Simple, But They Could Be Less Complex
In their article, Kamineni and colleagues report a well-conducted review of screening guidelines for 5 high-visibility cancer types to determine whether and how they considered harm. The editoriali...
- 1 November 2022
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 175 (11) , 1610-1611
Cancer Screening Guidelines Are Not Simple, But They Could Be Less Complex
In their article, Kamineni and colleagues report a well-conducted review of screening guidelines for 5 high-visibility cancer types to determine whether and how they considered harm. The editoriali...
- 25 June 2019
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 188 (10) , 1818-1820
Invited Commentary: Beyond Overdiagnosis—Diagnosis Without Benefit
In an accompanying article, Hofmann (Am J Epidemiol. 2019;188(10):1812–1817) seeks to clarify the concept of overdiagnosis by screening. He makes a helpful suggestion to reconnect diagnosis with patient suffering, pointing out the underlying issue in overdiagnosis of prognostic uncertainty. He then divides prognostic uncertainty into developmental and progression uncertainty, using a categorical model of disease progression through indicators to manifest disease. This model could be improved by considering the heterogeneity of patient-condition combinations. This leads to an understanding of the probabilistic nature of the connection between any indicator in a specific individual and patient suffering. The model also needs to consider the time span over which the patient-condition combination leads to patient suffering. I propose a simpler approach that goes further to focus not only on overdiagnosis but also on the broader problem of diagnosis without benefit and diagnosis without net benefit. This makes measurement easier and focuses attention where it belongs: on the harm caused by overly aggressive screening programs.
- 25 June 2019
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 188 (10) , 1818-1820
Invited Commentary: Beyond Overdiagnosis—Diagnosis Without Benefit
In an accompanying article, Hofmann (Am J Epidemiol. 2019;188(10):1812–1817) seeks to clarify the concept of overdiagnosis by screening. He makes a helpful suggestion to reconnect diagnosis with patient suffering, pointing out the underlying issue in overdiagnosis of prognostic uncertainty. He then divides prognostic uncertainty into developmental and progression uncertainty, using a categorical model of disease progression through indicators to manifest disease. This model could be improved by considering the heterogeneity of patient-condition combinations. This leads to an understanding of the probabilistic nature of the connection between any indicator in a specific individual and patient suffering. The model also needs to consider the time span over which the patient-condition combination leads to patient suffering. I propose a simpler approach that goes further to focus not only on overdiagnosis but also on the broader problem of diagnosis without benefit and diagnosis without net benefit. This makes measurement easier and focuses attention where it belongs: on the harm caused by overly aggressive screening programs.
- Open Access
- 12 January 2018
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 18 (1) , 5-5:9
A pre-post study testing a lung cancer screening decision aid in primary care
The United States Preventive Services Task Force (USPSTF) issued recommendations for older, heavy lifetime smokers to complete annual low-dose computed tomography (LDCT) scans of the chest as screening for lung cancer. The USPSTF recommends and the Centers for Medicare and Medicaid Services require shared decision making using a decision aid for lung cancer screening with annual LDCT. Little is known about how decision aids affect screening knowledge, preferences, and behavior. Thus, we tested a lung cancer screening decision aid video in screening-eligible primary care patients. We conducted a single-group study with surveys before and after decision aid viewing and medical record review at 3 months. Participants were active patients of a large US academic primary care practice who were current or former smokers, ages 55–80 years, and eligible for screening based on current screening guidelines. Outcomes assessed pre-post decision aid viewing were screening-related knowledge score (9 items about screening-related harms of false positives and overdiagnosis, likelihood of benefit; score range = 0–9) and preference (preferred screening vs. not). Screening behavior measures, assessed via chart review, included provider visits, screening discussion, LDCT ordering, and LDCT completion within 3 months. Among 50 participants, knowledge increased from pre- to post-decision aid viewing (mean = 2.6 vs. 5.5, difference = 2.8; 95% CI 2.1, 3.6, p < 0.001). Preferences across the overall sample remained similar such that 54% preferred screening at baseline and 50% after viewing; however, 28% of participants changed their preference (to or away from screening) from baseline to after viewing. We assessed screening behavior for 36 participants who had a primary care visit during the 3-month period following enrollment. Eighteen of 36 preferred screening after decision aid viewing. Of these 18, 10 discussed screening, 8 had a test ordered, and 6 completed LDCT. Among the 18 who preferred no screening, 7 discussed screening, 5 had a test ordered, and 4 completed LDCT. In primary care patients, a lung cancer screening decision aid improved knowledge regarding screening-related benefits and harms. Screening preferences and behavior were heterogeneous. This study is registered at www.clinicaltrials.gov . NCT03077230 (registered retrospectively,November 22, 2016).
- 12 January 2018
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 18 (1) , 5-5:9
Open AccessA pre-post study testing a lung cancer screening decision aid in primary care
The United States Preventive Services Task Force (USPSTF) issued recommendations for older, heavy lifetime smokers to complete annual low-dose computed tomography (LDCT) scans of the chest as screening for lung cancer. The USPSTF recommends and the Centers for Medicare and Medicaid Services require shared decision making using a decision aid for lung cancer screening with annual LDCT. Little is known about how decision aids affect screening knowledge, preferences, and behavior. Thus, we tested a lung cancer screening decision aid video in screening-eligible primary care patients. We conducted a single-group study with surveys before and after decision aid viewing and medical record review at 3 months. Participants were active patients of a large US academic primary care practice who were current or former smokers, ages 55–80 years, and eligible for screening based on current screening guidelines. Outcomes assessed pre-post decision aid viewing were screening-related knowledge score (9 items about screening-related harms of false positives and overdiagnosis, likelihood of benefit; score range = 0–9) and preference (preferred screening vs. not). Screening behavior measures, assessed via chart review, included provider visits, screening discussion, LDCT ordering, and LDCT completion within 3 months. Among 50 participants, knowledge increased from pre- to post-decision aid viewing (mean = 2.6 vs. 5.5, difference = 2.8; 95% CI 2.1, 3.6, p < 0.001). Preferences across the overall sample remained similar such that 54% preferred screening at baseline and 50% after viewing; however, 28% of participants changed their preference (to or away from screening) from baseline to after viewing. We assessed screening behavior for 36 participants who had a primary care visit during the 3-month period following enrollment. Eighteen of 36 preferred screening after decision aid viewing. Of these 18, 10 discussed screening, 8 had a test ordered, and 6 completed LDCT. Among the 18 who preferred no screening, 7 discussed screening, 5 had a test ordered, and 4 completed LDCT. In primary care patients, a lung cancer screening decision aid improved knowledge regarding screening-related benefits and harms. Screening preferences and behavior were heterogeneous. This study is registered at www.clinicaltrials.gov . NCT03077230 (registered retrospectively,November 22, 2016).
- 2 June 2015
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 162 (11) , 787-789
Incidental Findings in the Pancreas (and Elsewhere): Putting Our Patients (and Ourselves) in a Difficult Situation
- 2 June 2015
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 162 (11) , 787-789
Incidental Findings in the Pancreas (and Elsewhere): Putting Our Patients (and Ourselves) in a Difficult Situation
- 17 June 2014
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 160 (12) , 861-863
Screening Is Only Part of the Answer to Breast Cancer
- 17 June 2014
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 160 (12) , 861-863
Screening Is Only Part of the Answer to Breast Cancer
- 15 February 2013
- Vol. 87 (4) , 246-247
Screening Mammography: The Goal Is Changing
- Open Access
- 13 November 2012
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 12 (1) , 130
Shared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials
Professional societies recommend shared decision making (SDM) for prostate cancer screening, however, most efforts have promoted informed rather than shared decision making. The objective of this study is to 1) examine the effects of a prostate cancer screening intervention to promote SDM and 2) determine whether framing prostate information in the context of other clearly beneficial men’s health services affects decisions.
- 13 November 2012
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 12 (1) , 130
Open AccessShared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials
Professional societies recommend shared decision making (SDM) for prostate cancer screening, however, most efforts have promoted informed rather than shared decision making. The objective of this study is to 1) examine the effects of a prostate cancer screening intervention to promote SDM and 2) determine whether framing prostate information in the context of other clearly beneficial men’s health services affects decisions.
- 22 October 2012
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 172 (19) , 1462-1463
Time to Rethink Screening for Abdominal Aortic Aneurysm?
Opinion from JAMA Internal Medicine — Time to Rethink Screening for Abdominal Aortic Aneurysm? — Comment on “Impact of the Screening Abdominal Aortic Aneurysms Very Efficiently (SAAAVE) Act on Abdominal Ultrasonography Use Among Medicare Beneficiaries”
- 22 October 2012
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 172 (19) , 1462-1463
Time to Rethink Screening for Abdominal Aortic Aneurysm?
Opinion from JAMA Internal Medicine — Time to Rethink Screening for Abdominal Aortic Aneurysm? — Comment on “Impact of the Screening Abdominal Aortic Aneurysms Very Efficiently (SAAAVE) Act on Abdominal Ultrasonography Use Among Medicare Beneficiaries”
- Open Access
- 9 November 2011
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 103 (23) , 1726-1728
Less is More: Not "Going the Distance" and Why
- 9 November 2011
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 103 (23) , 1726-1728
Open AccessLess is More: Not "Going the Distance" and Why
- 1 September 2011
- Published by Elsevier in Preventive Medicine
- Vol. 53 (3) , 108-114
Breast cancer screening for women ages 50 to 69years a systematic review of observational evidence
- 1 September 2011
- Published by Elsevier in Preventive Medicine
- Vol. 53 (3) , 108-114
Breast cancer screening for women ages 50 to 69years a systematic review of observational evidence